It reports pathway-level variants in MTHFR, MTRR, and COMT that describe your baseline methylation and B12 biology, giving upstream context you can bring to a prescriber
A common titration approach includes: Week 12: 0.3 mg Week 34: 0.6 mg Week 56: 1.2 mg Week 78: 1.8 mg Week 9 and onward: 2.4 mg or higher, based on tolerance and clinical response Always consult a healthcare provider or licensed research facility for actual dosing guidance
Context determines the best choice
The companies selling BPC 157 and the media designed to boost its popularity focus on the part stating have demonstrated consistently positive and prompt healing effects for various injury types, but fail to mention the part stating, the majority of studies have been performed on small rodent models and the efficacy of BPC 157 is yet to be confirmed in humans. This means, simply, we have no evidence it works in human tissue
Presented for research literature review only Nakanishi T (2006)
~ AlphaMD Joe Rogan is more than just the voice behind the worlds most downloaded podcast